{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:39:27Z","timestamp":1790368767306,"version":"4.1.0"},"reference-count":61,"publisher":"Impact Journals, LLC","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2020,2,3]]},"DOI":"10.18632\/aging.102750","type":"journal-article","created":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T22:56:07Z","timestamp":1580770567000},"page":"2393-2407","source":"Crossref","is-referenced-by-count":32,"title":["Abnormal overexpression of G9a in melanoma cells promotes cancer progression via upregulation of the Notch1 signaling pathway"],"prefix":"10.18632","volume":"12","author":[{"given":"Ning-Ning","family":"Dang","sequence":"first","affiliation":[{"name":"Department of Dermatology, Jinan Central Hospital Affiliated to Shandong University, Jinan, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Jiao","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Jinan Central Hospital Affiliated to Shandong University, Jinan, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianguang","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Jinan Central Hospital Affiliated to Shandong University, Jinan, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhe","family":"An","sequence":"additional","affiliation":[{"name":"Beijing Center for Physical and Chemical Analysis, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Han","sequence":"additional","affiliation":[{"name":"Institute of Basic Medicine, The First Affiliated Hospital of Shandong First Medical University, Jinan, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhong","family":"Huang","sequence":"additional","affiliation":[{"name":"Institute of Basic Medicine, The First Affiliated Hospital of Shandong First Medical University, Jinan, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2020,2,3]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/978-3-030-02505-2_2","article-title":"Immunotherapy for Melanoma.","volume":"99","author":"Alqusairi","year":"2018","journal-title":"Adv Exp Med Biol"},{"key":"2","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s12254-018-0455-4","article-title":"ASCO Congress 2018: melanoma treatment.","volume":"1","author":"Richtig","year":"2018","journal-title":"Memo"},{"key":"3","doi-asserted-by":"publisher","first-page":"e0165591","DOI":"10.1371\/journal.pone.0165591","article-title":"Clinical Characteristics of Malignant Melanoma in Southwest China: A Single-Center Series of 82 Consecutive Cases and a Meta-Analysis of 958 Reported Cases.","volume":"1","author":"Lin","year":"2016","journal-title":"PLoS One"},{"key":"4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3760\/cma.j.issn.0529-5807.2018.01.003","article-title":"[Expert consensus on pathologic diagnosis of melanoma in China].","volume":"4","author":"Panel Members of Expert Consensus on Pathologic Diagnosis of Melanoma in China","year":"2018","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.humpath.2018.05.004","article-title":"Prognostic factors in primary anorectal melanoma: a clinicopathological study of 60 cases in China.","volume":"7","author":"Kong","year":"2018","journal-title":"Hum Pathol"},{"key":"6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3389\/fimmu.2015.00046","article-title":"Combining immunotherapy with oncogene-targeted therapy: a new road for melanoma treatment.","volume":"6","author":"Barrio","year":"2015","journal-title":"Front Immunol"},{"key":"7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.4161\/epi.23331","article-title":"G9a, a multipotent regulator of gene expression.","volume":"8","author":"Taneja","year":"2013","journal-title":"Epigenetics"},{"key":"8","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1101\/gad.2027411","article-title":"H3K9 methyltransferase G9a and the related molecule GLP.","volume":"2","author":"Tachibana","year":"2011","journal-title":"Genes Dev"},{"key":"9","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1093\/nar\/gky1230","article-title":"FOXO1 degradation via G9a-mediated methylation promotes cell proliferation in colon cancer.","volume":"4","author":"Seo","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10","doi-asserted-by":"publisher","first-page":"62081","DOI":"10.18632\/oncotarget.19060","article-title":"Methyltransferase G9a promotes cervical cancer angiogenesis and decreases patient survival.","volume":"8","author":"Lin","year":"2017","journal-title":"Oncotarget"},{"key":"11","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/s41419-018-0322-6","article-title":"G9A promotes gastric cancer metastasis by upregulating ITGB3 in a SET domain-independent manner.","volume":"9","author":"Huang","year":"2018","journal-title":"Cell Death Dis"},{"key":"12","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.humpath.2017.11.003","article-title":"The histone methyltransferase G9a: a new therapeutic target in biliary tract cancer.","volume":"7","author":"Neureiter","year":"2018","journal-title":"Hum Pathol"},{"key":"13","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41467-017-00350-9","article-title":"G9a regulates breast cancer growth by modulating iron homeostasis through the repression of ferroxidase hephaestin.","volume":"8","author":"Chen","year":"2017","journal-title":"Nat Commun"},{"key":"14","doi-asserted-by":"publisher","first-page":"477","DOI":"10.12122\/j.issn.1673-4254.2019.04.15","article-title":"[Expression of G9a in breast cancer and its effect on proliferation of breast cancer cells].","volume":"3","author":"Li","year":"2019","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"15","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3389\/fimmu.2015.00487","article-title":"Functional Role of G9a Histone Methyltransferase in Cancer.","volume":"6","author":"Lee","year":"2015","journal-title":"Front Immunol"},{"key":"16","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.ejmech.2019.06.072","article-title":"Recent progress in histone methyltransferase (G9a) inhibitors as anticancer agents.","volume":"17","author":"Chen","year":"2019","journal-title":"Eur J Med Chem"},{"key":"17","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/s41591-019-0499-y","article-title":"Inhibition of a G9a\/DNMT network triggers immune-mediated bladder cancer regression.","volume":"2","author":"Casares","year":"2019","journal-title":"Nat Med"},{"key":"18","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/s41401-018-0205-5","article-title":"Inhibition of G9a by a small molecule inhibitor, UNC0642, induces apoptosis of human bladder cancer cells.","volume":"4","author":"Yan","year":"2019","journal-title":"Acta Pharmacol Sin"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1093\/cdn\/nzz030.P05-010-19","article-title":"Cholesterol Biosynthesis Is Required for Cell Death in Response to G9A Inhibitor in Lung Cancer (P05-010-19).","volume":"3","author":"Park","year":"2019","journal-title":"Curr Dev Nutr"},{"key":"20","doi-asserted-by":"publisher","first-page":"e2726","DOI":"10.1038\/cddis.2017.65","article-title":"G9A promotes tumor cell growth and invasion by silencing CASP1 in non-small-cell lung cancer cells.","volume":"8","author":"Zhang","year":"2017","journal-title":"Cell Death Dis"},{"key":"21","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.3892\/ol.2014.2034","article-title":"Modulation of microRNA expression in human lung cancer cells by the G9a histone methyltransferase inhibitor BIX01294.","volume":"7","author":"Rennert","year":"2014","journal-title":"Oncol Lett"},{"key":"22","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/ncb3395","article-title":"G9a\/RelB regulates self-renewal and function of colon-cancer-initiating cells by silencing Let-7b and activating the K-RAS\/\u03b2-catenin pathway.","volume":"1","author":"Kuo","year":"2016","journal-title":"Nat Cell Biol"},{"key":"23","doi-asserted-by":"publisher","first-page":"7077","DOI":"10.1073\/pnas.1618706114","article-title":"G9a drives hypoxia-mediated gene repression for breast cancer cell survival and tumorigenesis.","volume":"11","author":"Lee","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"24","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1172\/JCI57349","article-title":"G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancer.","volume":"12","author":"Zhou","year":"2012","journal-title":"J Clin Invest"},{"key":"25","doi-asserted-by":"publisher","first-page":"4127","DOI":"10.3892\/ol.2017.5977","article-title":"G9A performs important roles in the progression of breast cancer through upregulating its targets.","volume":"1","author":"Li","year":"2017","journal-title":"Oncol Lett"},{"key":"26","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.3892\/mmr.2017.8190","article-title":"UNC0638, a G9a inhibitor, suppresses epithelial-mesenchymal transition-mediated cellular migration and invasion in triple negative breast cancer.","volume":"1","author":"Zhang","year":"2018","journal-title":"Mol Med Rep"},{"key":"27","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/1476-4598-13-189","article-title":"The H3K9 methyltransferase G9a is a marker of aggressive ovarian cancer that promotes peritoneal metastasis.","volume":"1","author":"Yen","year":"2014","journal-title":"Mol Cancer"},{"key":"28","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1158\/0008-5472.CAN-17-2506","article-title":"FIH Is an Oxygen Sensor in Ovarian Cancer for G9a\/GLP-Driven Epigenetic Regulation of Metastasis-Related Genes.","volume":"7","author":"Park","year":"2018","journal-title":"Cancer Res"},{"key":"29","doi-asserted-by":"publisher","first-page":"S1556","DOI":"10.1245\/s10434-015-4379-5","article-title":"The H3K9 Methyltransferase G9a Represses E-cadherin and is Associated with Myometrial Invasion in Endometrial Cancer.","volume":"2","author":"Wei","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"30","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/DAD.0b013e3182964e02","article-title":"Immunohistochemistry for histone h3 lysine 9 methyltransferase and demethylase proteins in human melanomas.","volume":"3","author":"Masuda","year":"2014","journal-title":"Am J Dermatopathol"},{"key":"31","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1038\/bjc.1996.563","article-title":"Immunohistochemical determination of oestrogen receptor: comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients.","volume":"7","author":"Rubens","year":"1996","journal-title":"Br J Cancer"},{"key":"32","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.pharmthera.2016.12.001","article-title":"Maximising the potential of AKT inhibitors as anti-cancer treatments.","volume":"17","author":"Banerji","year":"2017","journal-title":"Pharmacol Ther"},{"key":"33","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ceb.2017.02.007","article-title":"PI3K signaling in cancer: beyond AKT.","volume":"4","author":"Toker","year":"2017","journal-title":"Curr Opin Cell Biol"},{"key":"34","doi-asserted-by":"publisher","first-page":"e269","DOI":"10.1016\/j.clgc.2017.10.011","article-title":"The Current Status and Future Role of the Phosphoinositide 3 Kinase\/AKT Signaling Pathway in Urothelial Cancer: An Old Pathway in the New Immunotherapy Era.","volume":"1","author":"Drakaki","year":"2018","journal-title":"Clin Genitourin Cancer"},{"key":"35","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.semcancer.2017.04.018","article-title":"PKB\/Akt-dependent regulation of inflammation in cancer.","volume":"4","author":"Xue","year":"2018","journal-title":"Semin Cancer Biol"},{"key":"36","doi-asserted-by":"publisher","first-page":"104508","DOI":"10.1016\/j.dib.2019.104508","article-title":"Data on left ventricular expression of STAT3 and AKT in transgenic mouse models with B16F10 melanoma.","volume":"2","author":"Hilfiker-Kleiner","year":"2019","journal-title":"Data Brief"},{"key":"37","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13046-019-1138-7","article-title":"TRIM44 activates the AKT\/mTOR signal pathway to induce melanoma progression by stabilizing TLR4.","volume":"3","author":"Gu","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"38","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1080\/15384047.2018.1435221","article-title":"PI3K\/AKT\/mTOR pathway inhibitors inhibit the growth of melanoma cells with mTOR H2189Y mutations in vitro.","volume":"1","author":"Guo","year":"2018","journal-title":"Cancer Biol Ther"},{"key":"39","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1016\/j.bbrc.2018.06.175","article-title":"The miR-31-SOX10 axis regulates tumor growth and chemotherapy resistance of melanoma via PI3K\/AKT pathway.","volume":"50","author":"Wang","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"40","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/978-1-4614-0899-4_19","article-title":"Notch signaling and malignant melanoma.","volume":"72","author":"M\u00fcller","year":"2012","journal-title":"Adv Exp Med Biol"},{"key":"41","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/pcmr.12194","article-title":"Notch signaling in melanoma: interacting pathways and stromal influences that enhance Notch targeting.","volume":"2","author":"Bedogni","year":"2014","journal-title":"Pigment Cell Melanoma Res"},{"key":"42","doi-asserted-by":"publisher","first-page":"8931","DOI":"10.1021\/jm401480r","article-title":"Discovery of anchemical probe of the lysine methyltransferases G9a and GLP.","volume":"5","author":"Jin","year":"2013","journal-title":"J Med Chem"},{"key":"43","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1021\/acs.jmedchem.6b01645","article-title":"Discovery of Potent and Selective Inhibitors for G9a-Like Protein (GLP) Lysine Methyltransferase.","volume":"6","author":"Jin","year":"2017","journal-title":"J Med Chem"},{"key":"44","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/aps.2017.190","article-title":"Inhibition of the G9a\/GLP histone methyltransferase complex modulates anxiety-related behavior in mice.","volume":"3","author":"Wong","year":"2018","journal-title":"Acta Pharmacol Sin"},{"key":"45","doi-asserted-by":"publisher","first-page":"520590","DOI":"10.1155\/2015\/520590","article-title":"Roles of NOTCH1 as a Therapeutic Target and a Biomarker for Lung Cancer: controversies and Perspectives.","volume":"201","author":"Yang","year":"2015","journal-title":"Dis Markers"},{"key":"46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ceb.2018.06.010","article-title":"The multiple usages of Notch signaling in development, cell differentiation and cancer.","volume":"5","author":"Espinosa","year":"2018","journal-title":"Curr Opin Cell Biol"},{"key":"47","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s12032-017-1039-6","article-title":"Notch signaling pathway networks in cancer metastasis: a new target for cancer therapy.","volume":"3","author":"Liu","year":"2017","journal-title":"Med Oncol"},{"key":"48","doi-asserted-by":"publisher","first-page":"E431","DOI":"10.3390\/molecules23020431","article-title":"Taming the Notch Transcriptional Regulator for Cancer Therapy.","volume":"2","author":"Rehman","year":"2018","journal-title":"Molecules"},{"key":"49","doi-asserted-by":"publisher","first-page":"5","DOI":"10.21037\/sci.2018.02.02","article-title":"Targeting Notch signalling pathway of cancer stem cells.","volume":"5","author":"Basalingappa","year":"2018","journal-title":"Stem Cell Investig"},{"key":"50","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/modpathol.3800526","article-title":"Evidence for differential expression of Notch receptors and their ligands in melanocytic nevi and cutaneous malignant melanoma.","volume":"1","author":"Santucci","year":"2006","journal-title":"Mod Pathol"},{"key":"51","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10238-012-0190-9","article-title":"The involvement of Notch signaling in melanoma vasculogenic mimicry.","volume":"1","author":"Stepanova","year":"2013","journal-title":"Clin Exp Med"},{"key":"52","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.medici.2015.06.002","article-title":"Molecular alterations in signal pathways of melanoma and new personalized treatment strategies: targeting of Notch.","volume":"5","author":"Labeikyt\u0117","year":"2015","journal-title":"Medicina (Kaunas)"},{"key":"53","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1087-0024.2005.200404.x","article-title":"Notch and NOXA-related pathways in melanoma cells.","volume":"1","author":"Qin","year":"2005","journal-title":"J Investig Dermatol Symp Proc"},{"key":"54","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/pcmr.12764","article-title":"Notch signaling activation induces cell death in MAPKi-resistant melanoma cells.","volume":"3","author":"Setaluri","year":"2019","journal-title":"Pigment Cell Melanoma Res"},{"key":"55","doi-asserted-by":"publisher","first-page":"71211","DOI":"10.18632\/oncotarget.12078","article-title":"Targeting Notch enhances the efficacy of ERK inhibitors in BRAF-V600E melanoma.","volume":"7","author":"Samatar","year":"2016","journal-title":"Oncotarget"},{"key":"56","doi-asserted-by":"publisher","first-page":"4182","DOI":"10.1158\/0008-5472.CAN-05-3589","article-title":"Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase\/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression.","volume":"6","author":"Herlyn","year":"2006","journal-title":"Cancer Res"},{"key":"57","doi-asserted-by":"publisher","first-page":"3660","DOI":"10.1172\/JCI36157","article-title":"Notch1 is an effector of Akt and hypoxia in melanoma development.","volume":"11","author":"Powell","year":"2008","journal-title":"J Clin Invest"},{"key":"58","first-page":"1644","article-title":"Inhibition of Notch initiates anti-tumor effects in malignant melanoma.","volume":"6","author":"Herlyn","year":"2007","journal-title":"Cancer Res"},{"key":"59","doi-asserted-by":"publisher","first-page":"13510","DOI":"10.1073\/pnas.1106106108","article-title":"Hypoxia-induced methylation of a pontin chromatin remodeling factor.","volume":"10","author":"Baek","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"60","doi-asserted-by":"publisher","first-page":"9636","DOI":"10.1074\/jbc.M109.062588","article-title":"G9a and Glp methylate lysine 373 in the tumor suppressor p53.","volume":"28","author":"Berger","year":"2010","journal-title":"J Biol Chem"},{"key":"61","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s10549-010-0876-1","article-title":"Involvement of MyoD and c-myb in regulation of basal and estrogen-induced transcription activity of the BRCA1 gene.","volume":"12","author":"Shao","year":"2011","journal-title":"Breast Cancer Res Treat"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.102750","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T20:01:43Z","timestamp":1599076903000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.102750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,3]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,2,15]]}},"alternative-id":["102750","32015216"],"URL":"https:\/\/doi.org\/10.18632\/aging.102750","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,3]]}}}